Page 303 - Read Online
P. 303

Page 16 of 18                                       Zimmermann et al. Vessel Plus 2019;3:31  I  http://dx.doi.org/10.20517/2574-1209.2019.010

               61.  Nassif M, Abdelghani M, Bouma BJ, Straver B, Blom NA, et al. Historical developments of atrial septal defect closure devices: what
                   we learn from the past. Expert Rev Med Devices 2016;13:555-68.
               62.  Aytemir K, Oto A, Ozkutlu S, Canpolat U, Kaya EB, et al. Transcatheter interatrial septal defect closure in a large cohort: midterm
                   follow-up results. Congenit Heart Dis 2013;8:418-27.
               63.  Wang JK, Chiu SN, Lin MT, Chen CA, Lu CW, et al. Mid-to-long-term follow-up results of transcatheter closure of atrial septal defect
                   in patients older than 40 years. Heart vessels 2017;32:467-73.
               64.  Alnasser S, Lee D, Austin PC, Labos C, Osten M, et al. Long term outcomes among adults post transcatheter atrial septal defect closure:
                   Systematic review and meta-analysis. Int J Cardiol 2018;270:126-32.
               65.  Nicolay S, Salgado RA, Shivalkar B, Van Herck PL, Vrints C, et al. CT imaging features of atrioventricular shunts: what the radiologist
                   must know. Insights imaging 2016;7:119-29.
               66.  White HD, Halpern EJ, Savage MP. Imaging of adult atrial septal defects with CT angiography. JACC Cardiovasc Imaging
                   2013;6:1342-5.
               67.  Khoshpouri P, Khoshpouri P, Bedayat A, Ansari-Gilani K, Chalian H. Interatrial septum: A pictorial review of congenital and acquired
                   pathologies and their management. Clin Imaging 2019;55:53-64.
               68.  Song J, Kim Y, Aigerim T. Usefulness of cardiac computed tomography in transcatheter closure of atrial septal defect with amplatzer
                   septal occluder. Russ J of Cardiol 2013;47:35-9.
               69.  Chia RC, Salazar P, Al-Yafi M, Romano S, Farzaneh-Far A. Secundum Atrial Septal Defect. QJM 2018;111:571-2.
               70.  Lairakdomrong K, Srimahachota S, Lertsapcharoen P, Chaipromprasit J, Boonyaratavej S, et al. Clinical results of large secundum atrial
                   septal defect closure in adult using percutaneous transcatheter Cocoon atrial septal occluder. J Med Assoc Thai 2013;96:1127-34.
               71.  Thanopoulos BD, Biasco L, Dardas P, De Backer O, Avraamides P, et al. Catheter closure of atrial septal defects using the Cocoon
                   septal occluder: preliminary results of a European multicenter study. Int J Cardiol 2014;177:418-22.
               72.  Mijangos-Vázquez R, García-Montes AJ, Soto-López EM, Guarner-Lans V, Zabal C. Atrial septal defect closure with the new Cardia
                   Ultrasept II™ device with interposed Goretex patch: Mexican experience-has the perforation of Ivalon’s membrane been solved?
                   Cardiol Young 2018;28:709-14.
               73.  Bartel T, Bonaros N, Muller S. Device failure weeks to months after transcatheter closure of secundum type atrial septal defects. Heart
                   2010;96:1603.
               74.  Aubry P, Brochet E, du Fretay XH, Bouton-Brochet S, Ibrahim H, et al. Early malfunction of polyvinyl alcohol membrane-covered
                   atrial septal defect closure devices. Circ Cardiovasc Interv 2014;7:721-2.
               75.  Bozyel S, Sahin T, Dervis E, Aktas M, Saskin H. A massive left-to-right shunt due to delayed spontaneous perforation of polyvinyl
                   alcohol membrane of atrial septal occluder. Turk Kardiyol Dern Ars 2017;45:541-4.
               76.  Chamie F, Maia J, Giuliano LC. Device-in-device: a transcatheter alternative to surgical explantation of a failing atrial septal defect
                   intracardiac prosthesis. Catheter Cardiovasc Interv 2016;88:239-43.
               77.  Peirone A, Contreras A, Ferrero A, da Costa RN, Pedra SF, et al. Immediate and short-term outcomes after percutaneous atrial septal
                   defect closure using the new nit-occlud ASD-R device. Catheter Cardiovasc Interv 2014;84:464-70.
               78.  Bulut MO, Yucel IK, Kucuk M, Balli S, Basar EZ, et al. Initial experience with the Nit-Occlud ASD-R: short-term results. Pediatr
                   Cardiol 2016;37:1258-65.
               79.  Astarcioglu MA, Kalcik M, Sen T, Aykan AC, Gokdeniz T, et al. Ceraflex versus Amplatzer occluder for secundum atrial septal defect
                   closure. Multicenter clinical experience. Herz 2015;40 Suppl 2:146-50.
               80.  Apostolopoulou SC, Tsoutsinos A, Laskari C, Kiaffas M, Rammos S. Large single centre experience with the Cera and CeraFlex
                   occluders for closure of interatrial communications: usefulness of the flexible rotation feature. Cardiovasc Interv Ther 2018;33:70-6.
               81.  Kenny D, Eicken A, Dahnert I, Boudjemline Y, Sievert H, et al. A randomized, controlled, multi-center trial of the efficacy and safety of
                   the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal
                   defects. Catheter Cardiovasc Interv 2019;93:316-21.
               82.  Haas NA, Soetemann DB, Ates I, Baspinar O, Ditkivskyy I, et al. Closure of secundum atrial septal defects by using the occlutech
                   occluder devices in more than 1300 patients: the IRFACODE project: a retrospective case series. Catheter Cardiovasc Interv
                   2016;88:571-81.
               83.  Godart F, Houeijeh A, Recher M, Francart C, Polge AS, et al. Transcatheter closure of atrial septal defect with the Figulla® ASD
                   Occluder: a comparative study with the Amplatzer® Septal Occluder. Arch Cardiovasc Dis 2015;108:57-63.
               84.  Roymanee S, Promphan W, Tonklang N, Wongwaitaweewong K. Comparison of the Occlutech® Figulla® septal occluder and
                   Amplatzer® septal occluder for atrial septal defect device closure. Pediatr Cardiol 2015;36:935-41.
               85.  Kim AY, Jung SY, Chang JY, Jung JW, Choi JY. Early to mid-term follow-up outcomes of percutaneous closure of atrial septal defects
                   using recent generation devices: a single-center experience. Korean Circ J 2019;49:326-35.
               86.  O’Byrne ML, Glatz AC, Gillespie MJ. Transcatheter device closure of atrial septal defects: more to think about than just closing the
                   hole. Curr Opin Cardiol 2018;33:108-16.
               87.  de Hemptinne Q, Horlick EM, Osten MD, Millan X, Tadros VX, et al. Initial clinical experience with the GORE® CARDIOFORM
                   ASD occluder for transcatheter atrial septal defect closure. Catheter Cardiovasc Interv 2017;90:495-503.
               88.  Grohmann J, Wildberg C, Zartner P, Abu-Tair T, Tarusinov G, et al. Multicenter midterm follow-up results using the gore septal occluder
                   for atrial septal defect closure in pediatric patients. Catheter Cardiovasc Interv 2017;89:E226-32.
               89.  Turner DR, Owada CY, Sang CJ Jr, Khan M, Lim DS. Closure of secundum atrial septal defects with the AMPLATZER septal occluder:
   298   299   300   301   302   303   304   305   306   307   308